New discovery helps explain how COVID-19 suppresses the body’s immune response

Seeking to understand why COVID-19 is able to suppress the body's immune response, new research from the USC Leonard Davis School of Gerontology suggests that mitochondria are one of the first lines of defense against COVID-19 and identifies key differences in how SARS-CoV-2, the virus that causes COVID-19, interacts with mitochondrial genes when compared to other viruses.

These differences offer possible explanations as to why older adults and people with metabolic dysfunction have more severe responses to COVID-19 than other individuals, and they also provide a starting point for more targeted experiments that may help identify therapeutics, said senior author Pinchas Cohen, professor of gerontology, medicine and biological sciences and dean of the USC Leonard Davis School.

"If you already have mitochondrial and metabolic dysfunction, then you may, as a result, have a poor first line of defense against COVID-19. Future work should consider mitochondrial biology as a primary target for SARS-CoV-2 and other coronaviruses," he said.

The study, published January 8 in the Nature journal Scientific Reports, expands on recent findings that COVID-19 mutes the body's innate inflammatory response and reports that it seems to be doing so by telling mitochondrial genes what to do.

"We already knew that our immune response was not mounting a successful defense to COVID-19, but we didn't know why," said lead author Brendan Miller, a senior doctoral student in the Cohen Lab at the USC Leonard Davis School. "What we did differently was look at how the virus specifically targets mitochondria, a cellular organelle that is a crucial part of the body's innate immune system and energy production."

Making use of the vast amounts of public data being uploaded in the early days of the virus outbreak, the research team performed RNA sequencing analyses that compared mitochondrial-COVID interactions to those of other viruses: respiratory syncytial virus, seasonal influenza A virus, and human parainfluenza virus 3. These reanalyses identified three ways in which COVID-19, but not the other viruses, mutes the body's cellular protective response.

Chief among their findings is that SARS-CoV-2 uniquely reduces the levels of a group of mitochondrial proteins, known as Complex One, that are encoded by nuclear DNA. It is possible that this effect "quiets" the cell's metabolic output and reactive oxygen species generation, that when functioning correctly, produces an inflammatory response that can kill a virus, they say.

"COVID-19 is telling the cell not to make these Complex One-related proteins. That could be one way the virus continues to propagate," said Miller, who notes that this, along with the study's other observations, still needs to be validated in a targeted experiment.

The study also revealed that SARS-CoV-2 does not change the levels of the messenger protein, MAVS mRNA, that usually tells the cell an attack has happened. Normally, when this protein gets activated, it functions as an alarm system, warning the cell to self-destruct so that the virus cannot replicate, Miller said.

In addition, the researchers found that genes encoded by the mitochondria were not being turned on or off by SARS-CoV-2 - a process that is believed to produce energy that can help the cell evade a virus - at rates to be expected when confronted with a virus.

This study adds to a growing body of research on mitochondrial-COVID interactions and presents tissue- and cell-specific effects that should be carefully considered in future experiments."

Pinchas Cohen, Study Senior Author and Professor of Gerontology, Medicine and Biological Sciences, Dean of the Leonard Davis School, University of Southern California

Journal reference:

Miller, B., et al. (2021) Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples. Scientific Reports.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Uncovering the Role of Faulty Signalling in Immune Cell Development